To explore how c-myc is activated in T-ALL/lymphoma, the alternative splicing of FIR, the ratio of FIR/FIRΔexon2, and c-myc mRNA expression were examined in human leukemia samples (Figure 1E, Table S1). The gene discussed is MYC; the disease is lymphoma.